serum by Wilkinson et al. (15) . Antigen-bearing slide wells were prepared by covering each well of a 12-well microscope slide (Cel-Line Associates, Minotola, NJ) with 30 Al of a 2 X 109 cells/ml preparation of formalin-killed L. pneumophila, allowing the slides to air dry, fixing the slides in acetone for 15 min, and again allowing the slides to air dry. Serum was obtained from the animals by cardiac puncture just before sacrifice, serially diluted in an equal volume of PBS up to a concentration of 1 :1,024, and placed on an antigenbearing slide well. The slides were incubated at 37°C in 100% humidity for 30 min, rinsed in PBS, and soaked in a PBS bath for 10 min. Then, 20,ul of fluorescein-conjugated IgG fraction goat anti-guinea pig IgG (Fc fragment) (Cappel Laboratories, Cochranville, PA) was placed on each well, and the slides were incubated at 37°C in 100% humidity for 30 min and rinsed. The slides were viewed at X 1,000 with a fluorescence microscope (Nikon Inc., Garden City, NY) . The titer of each animal's serum was expressed as the reciprocal of the dilution which produced 2+ fluorescence staining of at least 50% of the L. pneumophila bacteria in a microscopic field.
Cutaneous Delayed-type Hypersensitivity. Guinea pigs were shaved over the back and flank and given intradermal injections at different sites in this area of various concentrations of formalin-killed L. pneumophila diluted in 0.1 ml of PBS . The diameter of areas of erythema and induration at the site of the injection was recorded at 24 and 48 h.
Lymphocyte Proliferation Assay. Guinea pigs were killed by hypercarbia . The bodies were soaked in Linbro 7X cleaning solution (Flow Laboratories, Inc., McClean, VA) and the spleens were removed using sterile technique. Spleens were placed in RPMI 1640 with penicillin (100 U/ml) and streptomycin (100 ug/ml) (Gibco) and ground to a pulp. The pulp was strained through a thin layer of nylon mesh to remove fibrous material, and the spleen cells in the liquid passing through the mesh were collected by centrifugation at 200 g for 10 min at 4°C . Residual erythrocytes were hypotonically lysed and isotonicity was restored as described (16) . The remaining splenic lymphocytes were washed by centrifugation and counted in a hemocytometer . For the lymphocyte proliferation assay, the lymphocytes were adjusted to a final concentration of 10'/ml in RPMI 1640 containing penicillin (100 U/ml), streptomycin, (100 ug/ml), and 10% FCS and incubated with various concentrations of formalin-killed L. pneumophila as antigen in a total volume of 100 ul in microtest wells (96-well flat-bottom tissue culture plate, Falcon Labware, Oxnard, CA) . As controls, some lymphocytes were incubated without antigen, and others were incubated with Con A. The lymphocytes were incubated at 37°C in 5% C02/95% air for 1-5 d. At the end of this incubation period, 0.25 ACi of [sH]thymidine (New England Nuclear, Boston, MA) was added to each well and the cells were incubated at 37°C in 5% C02/95% air for 2 h . Using a multisample automated cell harvester (Skatron, Inc., Sterling, VA), each well was washed with double-distilled water and the effluent was passed through a filtermat . Filtermat sections representing separate microtest wells were placed in scintillation vials and 2 ml of biofluor liquid scintillation cocktail (New England Nuclear) was added. After at least 24 h, the beta particle emission was measured in a beta scintillation counter (Beckman Instruments, Inc., Fullerton, CA).
Determination of Lowest Lethal Dose (LD) . L. pneumophila, prepared as described above, was diluted in EYB to concentrations of 106, 10 7, 5 X 10', 7.5 X 10", 108, 2 .5 X 108 , 5 X 108, and 109 CFU/ml. Groups of animals were exposed in the aerosol delivery system to aerosolized 10-ml aliquots of each of these concentrations of L. pneumophila . Over the subsequent week, the rectal temperature, weight, and any physical signs of illness such as lethargy, ruffled fur, labored respiration, grunting and death were recorded daily on each animal.
Quantitation of L. pneumophila in Pulmonary Tissue. In two independent experiments, five guinea pigs were immunized in the aerosol delivery system with 0.01 LD of L. pneumophila and five additional guinea pigs were exposed to buffer (controls) . 28 d later, all animals were exposed simultaneously to an aerosolized dose of 108 CFU/ml of L. pneumophila. One immunized and one control guinea pig were then killed at 1, 6, 24, 48, and 72 h after exposure. The animals were soaked in Linbro 7X cleaning solution (Flow Laboratories, Inc.) and the right lung was removed from each animal using sterile technique . Each lung was placed in 10 ml of sterile EYB and ground up with a mortar and pestle . The suspension from each animal was cultured on CYE agar and CYE agar without cysteine (to rule out tfie presence of contaminating bacteria) as described (1) .
Results Aerosol Infection of Guinea Pigs with L. pneumophila . We exposed guinea pigs to various concentrations (10'-109 CFU/ml) of live virulent L. pneumophila by aerosol and observed them for signs of infection. Animals exposed to ?106 CFU/ml consistently had fever with temperatures >_40°C 2-5 d after infection. Animals exposed to >5 X 10' CFU/ml consistently displayed weight loss during this period . Animals given a lethal dose exhibited labored respirations, grunting, lethargy, ruffled fur, and shivering before death, which occurred 2-9 d after exposure, depending on dose . At necropsy, on gross examination, the lungs were hemorrhagic and congested or mottled with whitish yellow areas of consolidation. L. pneumophila was isolated in high concentrations from the lung and spleen, and also from the pericardium when pericardial effusion was present.
To determine the LD of L. pneumophila, defined here as the lowest concentration of L. pneumophila that was lethal to the majority of guinea pigs, we exposed guinea pigs to various concentrations of aerosolized L. pneumophila in several experiments and determined the rates of survival. Results were highly consistent from one experiment to the next . Animals exposed to aerosols containing <10' CFU/ml, infrequently died (Table I ). In animals exposed to 10 8 CFU/ml, five of seven animals died; the two surviving animals exhibited typical premorbid signs of marked weight loss, labored respirations, and cyanotic extremities but they survived. Animals exposed to >_2.5 X 108 CFU/ml all died (Table I ). In view of these results, we defined the LD in this model as 108 CFU/ml. In subsequent experiments, all eight guinea pigs given 108 CFU/ml died; taken together with the previous data, this indicates that this dose is very near the LDIOO for this system . animals but not controls developed significant antibody titers ( Fig. 1 ). The median IFAb titer, expressed as the reciprocal of the highest positive dilution, from exposed guinea pigs was 32 . Titers of control animals from <1 (negative with undiluted serum) to 4; the median titer was <1 .
Guinea Pigs Exposed to Sublethal Concentrations of Aerosolized L. pneumophila
Develop Cutaneous Delayed-type Hypersensitivity. To study cutaneous delayedtype hypersensitivity, we immunized guinea pigs with 10' to 10' CFU/ml of aerosolized L. pneumophila and 2 wk later, we assayed the response of these and control (nonimmunized) animals to intradermal injections of formalin-killed L. pneumophila in concentrations ranging from 10 5 to 10 I°bacterial particles/ml (Table 11 , Exp. A) .
Immunized animals had markedly greater areas of erythema and induration than control animals at both 24 and 48 h. Differences between immunized and control animals were particularly significant at 24 h with antigen concentrations of 107 and 10' formalin-killed L. pneumophila/ml: at 108 formalin-killed L. pneumophila/ml, immunized animals had 9.6 ± 2 .4 mm of erythema and 7.3 ± 2.3 mm of induration, whereas controls had only 2 .5 ± 2 .5 mm of erythema and 0 mm of induration . At 107 formalin-killed L. pneumophila/ml, immunized animals had 7.8 ± 3.1 mm of erythema and 6.8 ± 3 .2 mm of induration, whereas controls had 0 mm of erythema and induration .
In a second experiment, we immunized four guinea pigs with an aerosolized concentration of >_10 6 CFU of L. pneumophila/ml and skin-tested these and control animals 1 mo later with antigen concentrations of 10 7 and 108 formalinkilled L. pneumophila/ml (Table II, Exp. B). Again, immunized animals had markedly greater areas of erythema and induration at both 24 and 48 h to both antigen concentrations . Differences between immunized and control animals were particularly significant with an antigen dose of 10 7 formalin-killed L. pneumophila/ml. At 24 h, immunized animals exhibited 8.5 ± 2.7 mm of erythema and 5 .8 ± 3.6 mm of induration, whereas control animals had 0 mm of erythema and 2 ± 2.8 mm of induration . At 48 h, immunized animals had 7.8 mm of erythema and 7.8 mm of induration, whereas controls had 0 mm of erythema and induration . Guinea pigs were sublethally infected with L. pneumophila, and 2 (Exp. A) or 4 (Exp . B) wk later, they and control guinea pigs were skin-tested with formalin-killed L. pneumophila, as described in the text. Data given as means ±SD.
Splenic Lymphocytes from Guinea Pigs Recovered from a Sublethal Infection with L. pneumophila Proliferate in Response to L. pneumophila Antigens. To determine whether immunized guinea pigs expand a population of lymphocytes that recognize L. pneumophila antigens, we studied the proliferative response of splenic lymphocytes from these animals to formalin-killed L. pneumophila . In preliminary experiments, we studied the proliferative responses of splenic lymphocytes that were incubated with formalin-killed L. pneumophila for various incubation times (1-7 d) and at various concentrations of lymphocytes per milliliter. We obtained maximal responses when lymphocytes were at a concentration of 107 cells/ml and incubated with antigen for 2 d. We therefore used this concentration of lymphocytes and this incubation time in subsequent experiments .
Splenic lymphocytes from immunized guinea pigs consistently proliferated strongly in response to L. pneumophila antigens in comparison to splenic lymphocytes from control animals at antigen concentrations of 106 to 10 8 formalinkilled L. pneumophila/ml (Table III) . Differences between immunized and control animals were most significant for antigen concentrations of 107 and 10' bacterial particles/ml . At 107 bacterial particles/ml, the mean determination for immunized animals was 7,727 ± 1,590 cpm (SE), whereas the mean determination for control animals was 2,397 ± 430 cpm; stimulation indices for immunized and control animals were 6.8 ± 1 .2 and 1 .7 ± 0.1, respectively. At 108 bacterial particles/ml, the mean determination for immunized animals was 15,957 ± 2,700 cpm, whereas the mean determination for control animals was 5,993 ± 2,700; stimulation indices for immunized and control animals were 14 .4 ± 1 .8 and 5.8 ± 0.9, respectively . Antigen concentrations of 109 bacterial particles/ml yielded strong proliferative responses in both immunized and control animals, and antigen concentrations of 10'°bacterial particles/ml yielded background levels of proliferation in all animals (data not shown) .
Guinea Pigs Recovered from Sublethal Aerosol Infection with L. pneumophila Are Protected against Lethal Aerosol Challenge. To determine whether guinea pigs immunized by exposure to sublethal concentrations of L. pneumophila are protected against lethal challenge, we performed two large rechallenge experiments. In the first experiment, 33 guinea pigs were divided into three equal groups and exposed to EYB alone (control guinea pigs), 0.1 LD (107 CFU of L. pneumophila/ml), or 0.01 LD (106 CFU of L. pneumophila/ml) . Fever of >40°C developed in all guinea pigs exposed to L. pneumophila by day 2 (21 guinea pigs) or day 3 in 6 of 11 guinea pigs in the 0.01 LD group, in 8 of 11 in the 0.1 LD group, and in 0 of 11 in the control group. Death occurred in two guinea pigs both in the 0 .1 LD group, 3 and 12 d after exposure . 1 mo after the first exposure, we challenged the animals with either 1, 3, or 10 LD of L. pneumophila (Table IV) . In animals given one LD, none of three control guinea pigs survived, but all six guinea pigs that had been sublethally infected with 0.1 or 0.01 LD survived. The three-LD challenge yielded the same results; i.e., none of three control guinea pigs and six of six sublethally infected guinea pigs survived. The 10-LD challenge was lethal for all guinea pigs in all three groups . As an additional experimental control, we exposed two guinea pigs (one in the control group and one in the group given 0 .01 LD) to EYB alone in the rechallenge part of the experiment ; as expected, both survived .
To confirm these results, we performed a second experiment in which we initially exposed 15 guinea pigs to 0.01 LD aerosolized L. pneumophila and 15 guinea pigs to aerosolized EYB alone (control guinea pigs). 15 of 15 guinea pigs exposed to L. pneumophila had temperatures >40°C by day 2 or 3, where 0 of 15 control guinea pigs had elevated temperatures . 11 of 15 guinea pigs exposed to L. pneumophila had some weight loss as did 6 of 15 controls . No guinea pig manifested ruffled fur or labored respirations . 1 mo after the first exposure, we exposed these animals to 1, 3, or 10 LD of aerosolized L. pneumophila as in the previous experiment (Table IV) ; 0 of 10 control animals survived challenge with one or three LD, whereas 10 of 10 immunized animals survived these doses. With the 10-LD challenge, none of five control animals survived, whereas two of five immunized animals survived. Interestingly, in these experiments, guinea pigs in the immunized groups but not control groups had fever on the first day after challenge. In the first experiment, all 12 immunized guinea pigs had temperatures of >40°C (mean 40 .7 ± 0 .36) on the first day after one-or three-LD challenge, whereas none of six control guinea pigs had a temperature of >40°C (mean 39 .2 ± 0.45) after the same challenge. Similarly, in the second experiment, 14 of 15 immunized guinea pigs had fever on the first day after challenge (mean 40 .6 ± 0 .46), whereas 0 of the 15 control animals was febrile (mean 39 .12 ± 0.46). The fever in immunized animals was transient and subsided often by the second day after challenge. In the first experiment, for example, only 1 of 10 guinea pigs (temperature could not be taken in 2) was febrile on the second day after challenge. Guinea pigs in both the immunized and control groups lost weight after challenge. In the first experiment, 10 of 12 immunized animals and 6 of 6 control animals exhibited weight loss after challenge with one of three LD . In the second experiment, all immunized and control animals displayed weight loss to challenge with these doses.
Guinea pigs in both the immunized and control groups exhibited other signs of illness in response to challenge with one or three LD, although the frequency was higher in the control group. The most frequently observed sign was labored respirations ; this occurred in 7 of 12 immunized animals and 6 of 6 controls . Ruffled fur was observed in 1 of 12 immunized animals and 3 of 6 controls .
Immunized Guinea Pigs Limit L. pneumophila Multiplication and Clear L. pneumophilafrom Their Lungs . To determine the fate of L. pneumophila in immunized guinea pigs, we challenged five guinea pigs recovered from sublethal infection (0.01 LD) and five control guinea pigs with a one-LD aerosol, killed them 1-72 h later, and determined CFU of L. pneumophila in their right lung. We performed two independent experiments (Fig. 2) . At 1 and 6 h after aerosol exposure, immunized and control guinea pigs had comparable numbers of CFU of L. pneumophila in their lungs in both experiments. By 24 h, the number of CFU markedly increased in both the immunized and control animals tested although the immunized animals had fewer bacteria (0.5 log fewer in the first experiment and 1 .5 log fewer in the second experiment). Thereafter, CFU in control animals increased further to 4 logs above the 1-h level of infection, whereas CFU in immunized animals decreased in both experiments. At 72 h, CFU in the immunized animals had fallen to approximately the 1-h level of infection which was 4.5 log below the level in the control guinea pigs at this time point in both experiments; in the first experiment, the control guinea pig died before necropsy at 72 h.
Discussion
We have demonstrated that sublethal infection with L. pneumophila produced protective immunity in vivo against this intracellular pathogen. Moreover, we have demonstrated that sublethal infection with L. pneumophila by the airborne route, the natural route of infection, protects against lethal challenge by this route of infection. The development of protective immunity parallels the development of humoral and cell-mediated immune responses. Previous studies have failed to demonstrate protective immunity to L. pneumophila in vivo (12, 13) . We believe this is because the challenge doses in those studies were so high that they overwhelmed the capacity of the immune system to counteract the challenge. In our study, sublethally infected guinea pigs were protected against one or three times the lowest lethal dose that killed nearly all guinea pigs (-LD, oo), but these animals were not protected against 10 times that dose . In the study by Baskerville et al . (12) , sublethally infected guinea pigs were challenged with 10 times the LD5o and not protected. In the study by Eisenstein et al. (13) , guinea pigs surviving a previous infection were challenged with 44 times the LD5o and were not protected.
In terms of lethality, the challenge doses we used, one and three times thê -LD,oo, were still very high in comparison to the doses encountered by humans in epidemics of Legionnaires' disease. In most epidemics, the fatality rate has been^-15 % in untreated cases. This dose would be roughly equivalent to 0 .1 LD in our system, i.e., 1/30 the highest challenge dose used . Thus, the protective immunity induced by sublethal infection is very strong .
Immunized animals but not controls exhibited pyrexia on the first day after challenge. This likely reflects an early inflammatory response to L. pneumophila in the immunized animals. In the study by Baskerville et al. (12) , immunized guinea pigs challenged with 10 times the LD5o died sooner than controls, even though the bacterial counts in the immunized animals were less than that of controls . It is possible that an early inflammatory response coming immediately after an overwhelming challenge resulted in the more rapid demise of these animals.
Cutaneous delayed-type hypersensitivity to L. pneumophila antigens developed in guinea pigs immunized by the aerosol route in our study. Cutaneous hypersensitivity to L. pneumophila antigens has previously been shown by Wong et al. (17) to develop in guinea pigs immunized by the intraperitoneal route with L. pneumophila and by the intradermal and intraperitoneal route with L. pneumophila antigens.
Lymphocyte proliferation to L. pneumophila antigens in vitro was also demonstrated in our study with splenic lymphocytes obtained from guinea pigs sublethally infected by the aerosol route. Splenic lymphocytes proliferated markedly 1-5 mo after guinea pigs were exposed to aerosols .
The right lungs of both immunized and control animals contained comparable numbers of bacteria immediately after exposure to a lethal concentration of L. pneumophila . In both the immunized and control animals, CFU did not significantly change between 1 and 6 h after aerosolization ; this parallels in vitro data that L. pneumophila multiplication does not take place for the first few hours after infection of mononuclear phagocytes during which time a specialized ribosome-lined vacuole is formed (18) . Between 6 and 24 h, CFU multiplied logarithmically in both control and immunized animals . However, between 24 and 48 h, bacterial CFU continued to increase logarithmically in the control animal but decreased in the immunized animal . This suggests that immune protective forces were marshalled and became effective during the first 24 h after exposure in the immunized animals. This may reflect the time required for the development of the activated state in mononuclear phagocytes exposed to lymphokines; such activated mononuclear phagocytes strongly inhibit L. pneumophila intracellular multiplication (4-6).
Since Legionnaires' disease is transmitted by the airborne route, aerosol infection of guinea pigs with L. pneumophila mimics the natural route of infection. Because the disease in guinea pigs closely resembles the disease in humans clinically and pathologically, aerosol infection of guinea pigs with L. pneumophila constitutes a superb animal model of Legionnaires' disease. As a number of other diseases of the lung are caused by intracellular pathogens that are transmitted by the airborne route (e.g., tuberculosis, psittacosis, Q fever, histoplasmosis, and tularemia), this model may also serve as an excellent one for studying general principles of host defense against lung infections caused by intracellular pathogens.
Summary
We have employed the guinea pig model of L. pneumophila infection, which mimics Legionnaires' disease in humans both clinically and pathologically, to study humoral and cell-mediated immune responses to L. pneumophila and to examine protective immunity after aerosol exposure, the natural route of infection. Guinea pigs exposed to sublethal concentrations of L. pneumophila by aerosol developed strong humoral immune responses. By the indirect fluorescent antibody assay, exposed guinea pigs had a median serum antibody titer (expressed as the reciprocal of the highest positive dilution) of 32, whereas control guinea pigs had a median titer of <1 . Sublethally infected (immunized) guinea pigs also developed strong cell-mediated immune responses. In response to L. pneumophila antigens, splenic lymphocytes from immunized but not control animals proliferated strongly in vitro, as measured by their capacity to incorporate [3H]thymidine . Moreover, immunized but not control guinea pigs developed strong cutaneous delayed-type hypersensitivity to intradermally injected L. pneumophila antigens.
Sublethally infected (immunized) guinea pigs exhibited strong protective immunity to L. pneumophila . In two independent experiments, all 22 immunized guinea pigs survived aerosol challenge with one or three times the lethal dose of L. pneumophila whereas none of 16 sham-immunized control guinea pigs survived (p < 0.0001 in each experiment) . Immunized guinea pigs were not protected significantly from challenge with 10 times the lethal dose. Immunized but not control animals cleared the bacteria from their lungs.
This study demonstrates that guinea pigs sublethally infected with L. pneumophila by the aerosol route (a) develop strong humoral immune responses to this pathogen, (b) develop strong cell-mediated immune responses and cutaneous delayed-type hypersensitivity to L. pneumophila antigens, (c) are protected against subsequent lethal aerosol challenge, and (d) are able to clear the bacteria from their lungs . The guinea pig model of L. pneumophila pulmonary infection is as an excellent one for studying general principles of host defense against pulmonary infections caused by intracellular pathogens.
